Michael C Burger

13PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 22, 2026
Spinal cord disease following CAR T-cell therapy with axicabtagene ciloleucel in a patient with high-grade B-cell lymphoma.

Clara Walter, Michael C Burger, Kai Siebenbrodt

|Feb 28, 2026
Comparative cross-methodological analysis of the IDH-wildtype glioblastoma tumor microenvironment.

Pinar Cakmak, Jennifer H Lun, Miriam Köhler

|Sep 05, 2025
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial.

Wolfgang Wick, Lisa-Marie Lanz, Antje Wick

|Mar 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma.

F Strassheimer, P Elleringmann, G Ludmirski

|Nov 14, 2023
Molecular Determinants of Calcitriol Signaling and Sensitivity in Glioma Stem-like Cells.

Sarah Rehbein, Anna-Lena Possmayer, Süleyman Bozkurt

|May 06, 2023
Intracranial injection of natural killer cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma.

Michael C Burger, Marie-Therese Forster, Annette Romanski

Pageof 3

Frequent Collaborators

3 joint publications

Christel Herold-Mende

2 joint publications

Süleyman Bozkurt

2 joint publications

Jennifer H Lun

2 joint publications

Benedikt Linder